Glenmark Pharma’s generic drug to treat psoriatic arthritis gets U.S. FDA approval

A phosphodiesterase 4 (PDE4) inhibitor, Apremilast is indicated for treating psoriatic arthritis plaque psoriasis and Behcet disease associated with oral ulcers.

from | The Hindu https://ift.tt/cdzixBV